Pulmonx Corporation LUNG
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 22.84M | 22.76M | 20.59M | 22.60M | 21.50M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 22.84M | 22.76M | 20.59M | 22.60M | 21.50M |
| Cost of Revenue | 5.44M | 5.01M | 4.54M | 5.06M | 5.45M |
| Gross Profit | 17.40M | 17.74M | 16.04M | 17.54M | 16.05M |
| SG&A Expenses | 20.03M | 21.77M | 24.10M | 22.86M | 25.60M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 30.33M | 31.81M | 33.54M | 32.50M | 35.90M |
| Operating Income | -7.49M | -9.06M | -12.96M | -9.90M | -14.39M |
| Income Before Tax | -8.24M | -9.95M | -13.51M | -10.24M | -13.83M |
| Income Tax Expenses | 151.00K | 133.00K | 149.00K | 186.00K | 128.00K |
| Earnings from Continuing Operations | -8.39M | -10.08M | -13.65M | -10.43M | -13.96M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.39M | -10.08M | -13.65M | -10.43M | -13.96M |
| EBIT | -7.49M | -9.06M | -12.96M | -9.90M | -14.39M |
| EBITDA | -7.18M | -8.84M | -12.84M | -9.57M | -14.15M |
| EPS Basic | -0.19 | -0.24 | -0.33 | -0.25 | -0.34 |
| Normalized Basic EPS | -0.12 | -0.15 | -0.20 | -0.15 | -0.21 |
| EPS Diluted | -0.19 | -0.24 | -0.33 | -0.25 | -0.34 |
| Normalized Diluted EPS | -0.12 | -0.15 | -0.20 | -0.15 | -0.21 |
| Average Basic Shares Outstanding | 43.18M | 42.47M | 41.90M | 41.40M | 40.94M |
| Average Diluted Shares Outstanding | 43.18M | 42.47M | 41.90M | 41.40M | 40.94M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |